Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?

Royal Brompton & Harefield NHS Foundation Trust

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease and Allied Conditions

Study type: Observational

Funder types: Other

Identifiers

NCT02261337

2013LF003H

Details and patient eligibility

About

This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.

Enrollment: 565 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with chronic respiratory disease who are able to complete the assessments.

Exclusion criteria

• Significant co-morbidities that would limit walking ability, exercise capacity or make exercise unsafe (e.g. unstable ischaemic heart disease, neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation).
• Any patient whom the Chief Investigator feels it is unsafe to exercise (e.g. unstable cardiovascular disease).